GlaxoSmithKline is a leading, research-based pharmaceutical company with a diverse combination of skills, resources, and capabilities that provide a platform from which to perform effectively in today's rapidly changing healthcare environment.

GlaxoSmithKline was established in December 2000 from the equal merger of GlaxoWellcome and SmithKline Beecham. The two companies, themselves the products of mergers in the past, originally began as individual, private companies founded during the 19th century. By the end of the 20th century, both companies had already become world-class pharmaceutical corporations in their own right. Due to the successful merger of these two global pharmaceutical giants, GlaxoSmithKline is well positioned to become the indisputable leader of the pharmaceutical industry worldwide.

GSK has leadership in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products. The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products and nutritional healthcare drinks, all of which are among the market leaders.

The Based on 2004 Annual Results, GlaxoSmithKline had sales of ?20.3 billion (US$37.2 billion). Total pharmaceutical turnover (including vaccine) was just over ?17 billion (US$31 billion) and consumer healthcare turnover was ?3.2 billion (US$5.8 billion).

Headquartered in the UK and with operations based in the US, the new company is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market.

GlaxoSmithKline has 82 manufacturing sites in 37 countries that supply products to 191 global markets. GlaxoSmithKline has over 100,000 highly skilled and dedicated employees worldwide.

Add:
#1 Guang Hua Road,
Chaoyang District,
Beijing 100020, China

Tel: +86 10 8529 6868
Fax: +86 10 8529 6767